Immunogenicity risk assessment of synthetic peptide drugs and their impurities.

MLA

De Groot, Anne S., et al. “Immunogenicity Risk Assessment of Synthetic Peptide Drugs and Their Impurities.” Drug Discovery Today, vol. 28, no. 10, Oct. 2023, p. 103714. EBSCOhost, https://doi.org/10.1016/j.drudis.2023.103714.

APA

De Groot, A. S., Roberts, B. J., Mattei, A., Lelias, S., Boyle, C., & Martin, W. D. (2023). Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discovery Today, 28(10), 103714. https://doi.org/10.1016/j.drudis.2023.103714

Chicago

De Groot, Anne S, Brian J Roberts, Aimee Mattei, Sandra Lelias, Christine Boyle, and William D Martin. 2023. “Immunogenicity Risk Assessment of Synthetic Peptide Drugs and Their Impurities.” Drug Discovery Today 28 (10): 103714. doi:10.1016/j.drudis.2023.103714.